Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Speranskaya, V. Amosov, L. Novikova, V. Zolotnitskaya, O. Lukina (Saint- Petersburg, Russian Federation). Opportunities of SPECT-CT in the diagnosis of vascular complications of interstitial lung diseases. Eur Respir J 2010; 36: Suppl. 54, 791

Member's Comments

No comment yet.

Related content which might interest you: Clinical pitfalls in diagnosing interstitial lung disease Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Role of imaging in progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180073; 10.1183/16000617.0073-2018 Year: 2018 Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021 Year: 2022 Novel evaluation of pulmonary hypertension with chronic lung disease by perfusion SPECT/CT Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases Source: International Congress 2017 – Rare diseases Year: 2017 Prognostic validation of cryobiopsy for the diagnosis of interstitial lung diseases Source: International Congress 2019 – Transbronchial cryobiopsy and endobronchial ultrasound Year: 2019 Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders Year: 2015 Cryobiopsy in the diagnosis of diffuse parenchymal lung diseases: diagnostic strategy and complications in 699 patients Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Complications and mortality of tranbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Imaging of interstitial lung diseases Source: International Congress 2019 – PG7 Chest radiology Year: 2019 Prognostic value of dual-time-point 18F-FDG PET in fibrotic idiopathic interstitial pneumonia Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Usefulness of bronchoscopy in acute interstitial lung diseases Source: International Congress 2018 – PG6 Bronchoscopy in pulmonary emergencies Year: 2018 Comorbidities in interstitial lung diseases Source: Eur Respir Rev 2017; 26: 160027 Year: 2017 Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021